In Brief: Minoxidil study
This article was originally published in The Tan Sheet
Minoxidil study: In a randomized, double-blind study of 22 women who suffered hair loss as a result of adjuvant chemotherapy after breast surgery, the period of baldness before first hair regrowth was shortened by a mean of 50.2 days in those using 2% minoxidil rather than placebo, Madeleine Duvic, MD, M.D. Anderson Cancer Center, et al. report in the July issue of the Journal of the American Academy of Dermatology. The study was supported by a grant from Upjohn; Pharmacia & Upjohn markets OTC Rogaine 2% minoxidil hair regrowth treatment...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC